Decision Resources, Inc. Acquires Arlington Medical Resources, Inc.
Acquisition Expands Decision Resources, Inc.'s Market Research Expertise in the Antibiotic, Antifungal and Diagnostic Imaging Markets
WALTHAM, Mass. and MALVERN, Pa., Dec. 19 -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare industry insight and analysis, announced today that it acquired Arlington Medical Resources, Inc. (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries. The acquisition of Malvern, PA-based AMR by Waltham, MA-based Decision Resources, Inc. will result in a significant expansion of Decision Resources, Inc.'s infectious disease and diagnostic imaging market research and database franchises.
"AMR is eager to begin its next phase of growth with Decision Resources, Inc.," said Don Merrill, co-founder of AMR. "Our Market Guides that track the clinical usage of specific drugs and imaging procedures, primarily in the hospital setting, are considered the industry standard. We know that our products and services fit perfectly with the overall mission of Decision Resources, Inc. -- providing quality analysis of commercially important healthcare markets. We are delighted to be part of this growing, exciting organization."
Clinical Usage Databases Offer Pharmaceutical and Diagnostic Imaging Companies Unique Insight
AMR offers clinical databases that directly monitor the usage of antibiotics and antifungals within the hospital setting, and that of contrast media within various imaging market segments. This unique insight allows pharmaceutical companies to better understand how their products and their competitors' products are being used in the multiple geographic markets monitored.
"By adhering to a strict consistent methodology for data collection and having cultivated strong relationships with our respondent network, AMR has been able to achieve a unique, sophisticated level of reporting," said Paul Ferris, co-founder of AMR. "Not only has our growth been due to our discipline of collecting data, but our loyal clients are fans because we offer the flexibility to slice the datasets as their needs dictate. We look forward to continuing our important work for the pharmaceutical industry as part of Decision Resources, Inc."
Targeted Acquisition Part of Decision Resources, Inc.'s Overall Growth Strategy
The acquisition is part of an aggressive growth strategy by Decision Resources, Inc. Decision Resources, Inc.'s current business units include HealthLeaders-InterStudy, which provides managed care insight, Millennium Research Group, which provides medical device market research, and Decision Resources, which provides drug market analysis. The addition of AMR brings yet another layer of expertise with its distinct understanding of the usage of anti-infective drugs within the hospital setting and the worldwide practice of diagnostic imaging.
AMR is an important acquisition in Decision Resources, Inc.'s overall strategy to grow and strengthen our portfolio of quality research and analysis of the healthcare markets," said Peter Hoenigsberg, CEO of Decision Resources, Inc. "We are fast becoming the 'go-to' firm for clients looking to better understand the dynamics of the ever-evolving global healthcare landscape. The common thread throughout all our business units is the quality of research we provide and AMR fits perfectly into our operation."
AMR will remain headquartered in Malvern, PA.
Berkery Noyes initiated the transaction on behalf of AMR, acted as its financial advisor, and represented it in its negotiations with Decision Resources, Inc.
About AMR
AMR is a pharmaceutical market research firm serving the market intelligence needs of the pharmaceutical and diagnostic imaging industries since 1991. With offices in Malvern, PA and Brussels and affiliates in Tokyo, Seoul and Shanghai, AMR conducts syndicated audits in the United States, Italy, Germany, United Kingdom, France, Spain, China, Japan and Korea. Research includes clinical inpatient databases that directly link anti- infective drug with indication/procedure, formulary and stocking status tracking studies, drug purchasing audits and diagnostic imaging procedure volume/contrast media usage audits.
About Decision Resources
Decision Resources, Inc. is a world leader in healthcare market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. The company provides insight on the managed care industry (www.HealthLeaders-InterStudy.com), the medical device industry (www.MRG.net) and the pharmaceutical and drug industry (www.DecisionResources.com).
For more information, contact:
Elizabeth Marshall
Decision Resources, Inc.
781-296-2563
emarshall@dresources.com
Source: Decision Resources
Web site: www.decisionresources.com/
http://www.mrg.net/
http://www.healthleaders-interstudy.com/
